Is Pulmatrix Inc (PULM) overvalued? · $5.4M cap
Pulmatrix Inc (PULM) is a biotechnology company listed on NASDAQ.
This page asks whether Pulmatrix Inc (PULM) looks expensive on cached numbers — not a short thesis.
No cached income statement for PULM, so there is no earnings base to call rich or cheap.
PULM currently screens at market cap $5.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PULM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PULM stock page for the full model, not this heading.
Not investment advice.